Business Wire

GEKKOVET-OY

17.6.2021 11:34:12 CEST | Business Wire | Press release

Share
GekkoVet Oy: Has My Dog Got Corona Virus Disease, Cholangitis or Kennel Cough?

There are hundreds of different diseases and even more symptoms that can affect pets. Even a veterinarian cannot remember all of them without help. The new GekkoCompass application, recently launched by a Finnish company, suggests the most probable diagnosis and the appropriate treatment at the touch of a button to the veterinarian.

In treating their patients, veterinarians use numerous different sources to arrive at a diagnosis. Now, however, there is no longer a need for stacks of books or confusing notes. GekkoCompass creates a list of possible diagnoses in probability order, based on the patient’s symptoms, laboratory results, and other findings. After the diagnosis is selected, the appropriate treatments are suggested to the veterinarian. GekkoCompass provides support throughout the patient's treatment chain reducing the risk of human error at all stages. It does not forget things and preconceptions will not influence the diagnoses suggested.

GekkoCompass currently includes information for internal diseases of dogs and cats. With these alone there are nearly 25,000 different disease-symptom combinations. The content will grow to embrace new animal species as well as different fields of veterinary medicine. All this information is available to all veterinarians worldwide - regardless of the level of veterinary education or the country’s resources.

Johanna Majamaa, CEO of GekkoVet Oy, states: “The main idea behind this application’s development has been the desire to promote animal welfare worldwide. With GekkoCompass, the veterinarian will find diagnoses and recommended treatments faster and with greater confidence. At the same time, information is accumulated as veterinary medicine real world data (RWD). This is the first time ever when this data is automatically structured along the patient treatment path. PetCompass, a sister product that we have just launched, arose out of this same idea, but is intended for pet owners. We thought, why not provide professional-level information to animal owners as well and facilitate the flow of information between owners and veterinarians?”

Until now, pet owners have had to look for pet health information from a variety of sources, the reliability of which varies greatly. Now up-to-date information on the pet’s condition is easily available in one place through the PetCompass mobile app.

GekkoVet Oy is working with If P&C Insurance, which offers its dog and cat insurance customers the Premium version of the PetCompass application for 3 months free of charge. “During the corona pandemic, the number of new pet owners has grown sharply. We want to help, especially, the less experienced dog and cat owners by offering peace of mind in the different everyday situations that they and their pets find themselves in. The application provides a reliable and effortless way to discover the causes of a pet's symptoms and to easily get in touch with a veterinarian (or a remote veterinarian) if this is necessary,” says Heidi Elomaa, If's veterinarian and Product Manager for Animal Insurance.

Link:

ClickThru

Social Media:

https://www.facebook.com/gekkovet

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor10.11.2026 19:14:00 CET | Press release

PIMJETMI is a new once-daily oral systemic treatment option for certain U.S. patients with symptomatic tenosynovial giant cell tumor (TGCT)In the Phase 3 MANEUVER trial, PIMJETMI demonstrated early1 and durable2 tumor response with clinically meaningful improvements in all clinical outcome assessments, including physical function and painPIMJETMI has shown high objective response rate (ORR) with a manageable safety profileNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has approved PIMJETMI® (pimicotinib), a once-daily oral colony stimulating factor-1 receptor (CSF-1R) inhibitor, as a systemic treatment for adults with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection may cause worsening functional limitation or severe morbidity. “People living with TGCT have long faced difficult treatment decisions as they navigate a disease that can significant

Smartsheet Integrates With Claude Sheets, Making It Easy to Start Projects in Claude and Launch Workflows Across Teams with Smartsheet10.11.2026 18:57:00 CET | Press release

New Send to Smartsheet feature moves work started in Claude into Smartsheet, where the Execution Graph connects it to the people, plans and goals that see it through Smartsheet, the AI-powered enterprise work management platform, today announced a new integration with Claude Sheets, the new spreadsheet artifact in Claude from Anthropic, now in beta. With the new Send to Smartsheet feature, people who build a tracker or plan in Claude can move it into Smartsheet in a few clicks. There they can put it to work with their team, connected to the plans, projects, people and systems their organization already runs on. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110763156/en/ With the new Send to Smartsheet feature, people who build a tracker or plan in Claude can move it into Smartsheet in a few clicks. More and more work now begins in a conversation with Claude, and the Smartsheet MCP connector for Claude puts the entire pow

InterSystems Joins Google Cloud as Launch Partner for Gemini for Healthcare10.11.2026 18:00:00 CET | Press release

Integration with InterSystems IRIS FHIR MCP will help healthcare organizations securely connect Gemini to trusted, standards-based health data InterSystems, a creative data technology provider powering more than one billion health records globally, today announced that it will serve as a launch partner for Google Cloud’s Gemini for healthcare. Through the collaboration, Gemini for healthcare will connect to the InterSystems IRIS FHIR Model Context Protocol (MCP) server, enabling healthcare organizations to give AI assistants and agents governed access to FHIR data. The integration will bring together Google Cloud’s Gemini capabilities and the standards-based data access provided by InterSystems IRIS FHIR MCP. InterSystems FHIR MCP serves the open Model Context Protocol directly from a FHIR endpoint, allowing MCP-enabled clients to discover and use FHIR tools for searching, reading, creating, updating, and managing healthcare data. “Healthcare organizations are looking for practical way

Coherent Solutions Launches AKTIV, a Dedicated Fitness and Wellness Technology Business Unit10.11.2026 16:34:00 CET | Press release

Coherent Solutions officially launches AKTIV, a dedicated business unit focused exclusively on fitness and wellness technology. AKTIV brings together over 15 years of fitness industry experience, dedicated leadership, and global engineering capabilities to help fitness and wellness operators and equipment manufacturers compete through technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110242555/en/ Coherent Solutions officially launches AKTIV “We know the fitness and wellness industry and the challenges operators and manufacturers face. With AKTIV, we spend less time defining what needs to be built and more time delivering solutions that improve operations, member experiences, and business performance,” said Vadim Bartlov, Managing Director of AKTIV. AKTIV builds on Coherent Solutions' established work with leading fitness companies, including Life Time, Planet Fitness, Anytime Fitness, Orangetheory, and BowFlex,

Mouser Explores the Newest Computing Technologies Beyond Moore's Law in its Technology Series10.11.2026 16:12:00 CET | Press release

Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, today announced the latest installment of its Empowering Innovation Together (EIT) technology series, Moving Beyond Moore's Law. The series explores how engineers are advancing computing performance as traditional semiconductor scaling approaches its physical limits, from chiplets and advanced packaging to silicon photonics and emerging transistor technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261006980414/en/ Explore what comes after Moore's Law as the industry seeks new paths to computing performance. As a key driver of semiconductor advancement, Moore's Law has served as a roadmap for the industry, describing the trend of transistor counts on integrated circuits doubling approximately every two years. With conventional silicon transistors becoming increasingly difficult to shr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye